Dr Rosalynn Nazarian | Massachusetts General Hospital

Dr. Rosalyn M. Nazarian’s clinical and research interests include the skin pathology of inflammatory and fibrosing diseases. He serves on the Board of Directors and Medical Advisory Council of the Global Fibrosis Foundation and is the recipient of their 1st Junior Research Grant Award for his research on signaling pathway activation in nephrogenic systemic fibrosis, scleroderma, and keloids.

His academic interests include wound repair, helper T-cell immune phenotypes in psoriasis and atopic dermatitis, adverse drug reactions, calciphylaxis, molecular targeting in basaloid and squamous neoplasms, and Kaposi’s sarcoma. He has led investigations on immune dysregulation in acute erythroderma and chronic dermatitis for which he earned the Eleanor and Miles Shore Fellowship Award. He is the recipient of the Mass General Brigham in Excellence Award for Leadership and Innovation.

Dr. Nazarian teaches at Harvard Medical School and continuing medical education courses. He has lectured at the American Society of Dermatopathology, the American Academy of Dermatology, and the United States and Canadian Academies of Pathology, and has contributed more than 100 articles to the peer-reviewed literature. Dr. Nazarian is an Associate Editor of the Journal of Cutaneous Pathology, a member of the Peer Review Committee of the American Society of Dermatopathology, a member of the Diversity Committee of the Department of Pathology at Massachusetts General Hospital, and serves as a dermatopathology consultant on challenging telepathology cases. Tanzania and Kenya.